Holen Sie sich die Stockscreener-App
49.78
0.15%
0.2511
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
Tempus AI, Inc. $TEM Shares Acquired by Landscape Capital Management L.L.C. - MarketBeat
Tempus AI, Inc. $TEM Shares Acquired by BNP Paribas Financial Markets - MarketBeat
Assessing Tempus AI (TEM) Valuation As New Oncology Study Highlights Clinical Impact Of Its AI Platform - simplywall.st
Tempus AI Inc (TEM) Shares Down 5.14% on Mar 12 - GuruFocus
Top Artificial Intelligence Stocks To Watch NowMarch 12th - MarketBeat
Tempus AI Expands Clinical Validation of AI-Powered Cancer Diagnostics - Yahoo Finance
First Trust Advisors LP Has $47.63 Million Position in Tempus AI, Inc. $TEM - MarketBeat
Cathie Wood’s ARK sells LY Corp stock, buys Tempus AI - Investing.com
Promising Artificial Intelligence Stocks To Follow TodayMarch 11th - MarketBeat
Why Tempus AI Stock Is Up Wednesday? - Benzinga
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings - Business Wire
Tempus AI: Underappreciated Oncology Platform and Data Business Poised for Reimbursement Upside and AI-Driven Growth - TipRanks
Tempus AI Earnings Call Highlights Strong Growth Path - TipRanks
Hims and Hers Expands Consumer-Focused Digital Health Platform - The Globe and Mail
Best Artificial Intelligence Stocks To Watch TodayMarch 10th - MarketBeat
H.C. Wainwright raises Tempus AI stock price target on partnerships - Investing.com
Best Artificial Intelligence Stocks Worth WatchingMarch 9th - MarketBeat
HC Wainwright Forecasts Strong Price Appreciation for Tempus AI (NASDAQ:TEM) Stock - MarketBeat
Tempus AI Inc (TEM) Stock Price Down 3.2% on Mar 9 - GuruFocus
Should You Buy, Hold or Sell Tempus AI Stock Heading Into 2026? - The Globe and Mail
Should You Consider Purchasing, Retaining, or Selling Tempus AI Shares as 2026 Approaches? - Bitget
Assessing Tempus AI (TEM) Valuation After Expanded Merck Collaboration Announcement - Yahoo Finance
Tempus AI Deepens Merck Collaboration As Pharma Demand And Losses Evolve - Yahoo Finance
Artificial Intelligence Stocks To Keep An Eye OnMarch 7th - MarketBeat
Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine - Insider Monkey
Top Artificial Intelligence Stocks To Follow TodayMarch 6th - MarketBeat
Merck’s Oncology Pipeline Progress And Valuation Gap After Tempus AI Deal - Sahm
AI-Powered Tempus Inks New Multi-Year Merck Deal - Yahoo Finance Singapore
TEM's Diagnostics Arm Expanding Rapidly: What's Driving the Growth? - TradingView
TD Asset Management Inc Takes Position in Tempus AI, Inc. $TEM - MarketBeat
ARK Investment Management LLC Has $579.16 Million Position in Tempus AI, Inc. $TEM - MarketBeat
Amova Asset Management Americas Inc. Has $279.47 Million Stake in Tempus AI, Inc. $TEM - MarketBeat
Is Tempus AI, Inc. (TEM) A Good Stock To Buy Now? - Insider Monkey
Director David R. Epstein sells Tempus AI (TEM) shares under 10b5-1 plan - Stock Titan
Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era - The Cancer Letter
Tempus’ growth can’t shake Wall Street’s worries - Crain's Chicago Business
What Does the Market Think About Tempus AI Inc? - Benzinga
Why Tempus AI Stock Is Up Today — And What to Watch Before Next Week’s Earnings - AOL.com
TEM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Tempus AI expands collaboration with Merck on precision medicine By Investing.com - Investing.com Australia
Merck’s Oncology Results And Tempus AI Deal Reframe Post Keytruda Future - simplywall.st
Top Artificial Intelligence Stocks To Add to Your WatchlistMarch 3rd - MarketBeat
Morgan Stanley Lowers Price Target for Tempus AI (TEM) to $70 | - GuruFocus
Tempus AI (NASDAQ:TEM) Price Target Lowered to $70.00 at Morgan Stanley - MarketBeat
Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes - Benzinga
Merck (MRK) Partners with Tempus AI for Precision Oncology Advan - GuruFocus
Merck to collaborate with Tempus AI on precision oncology - Seeking Alpha
Tempus AI, Inc. Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine - marketscreener.com
Tempus announces strategic collaboration agreement with Merck to accelerate AI-driven precision medicine - marketscreener.com
Tempus AI, Merck Collaborate on AI-Driven Precision Medicine - marketscreener.com
Tempus AI expands collaboration with Merck on precision medicine - Investing.com India
Tempus Announces Strategic Collaboration Agreement With Merck To Accelerate Ai-Driven Precision Medicine - TradingView
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine - The Joplin Globe
Tempus AI, Inc. $TEM Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
34,648 Shares in Tempus AI, Inc. $TEM Acquired by Intech Investment Management LLC - MarketBeat
Tempus AI (TEM) Is Down 6.9% After Raising 2026 Outlook And Filing ESOP Shelf Offering - simplywall.st
Quantbot Technologies LP Buys Shares of 50,089 Tempus AI, Inc. $TEM - MarketBeat
0.84%
1.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):